Early Lyme Disease and Erythema Migrans — The Bull's-Eye Rash, Flu-Like Illness, and Early Dissemination
Table of Contents
- What Is Erythema Migrans?
- The Biology of the Tick Bite
- How the Rash Develops and Expands
- When There Is No Rash
- The Flu-Like Prodrome
- Early Disseminated Lyme — Spreading Through the Body
- Lyme Carditis in Early Dissemination
- Neurological Signs in Early Dissemination
- Who Is Most Vulnerable?
- When to See a Doctor Right Away
- Research Papers
- Connections
- Featured Videos
What Is Erythema Migrans?
Erythema migrans (EM) — Latin for "migrating redness" — is the skin rash that defines early Lyme disease and is the single most diagnostically important sign of Borrelia burgdorferi infection. When a physician sees an expanding red rash meeting the diagnostic criteria in an endemic region, treatment should begin immediately, without waiting for blood tests. Serology in the first few weeks of infection is frequently negative because the antibody response takes time to develop, and delaying treatment to wait for confirmatory testing means missing the critical window when antibiotics work most reliably.
By definition, erythema migrans must be at least 5 centimeters in diameter — a threshold that helps distinguish it from a simple tick-bite reaction, which typically measures 1 to 2 cm and resolves within 24 to 48 hours. The EM rash appears at or near the site of the tick bite, typically 3 to 30 days (median 7 days) after the tick detaches.
The rash that most people picture — a red bull's-eye with a central red spot, a clear ring, and an outer red ring — is actually present in fewer than half of documented EM cases. Studies from endemic US communities consistently find that 50 percent or more of EM rashes are uniformly red, without any central clearing. This matters enormously for patients and clinicians: a solid red, warm, expanding oval that appeared near an outdoor activity does not need to look like an archery target to be taken seriously. The absence of a bull's-eye pattern is not grounds for dismissal.
The rash is usually painless (though it may be mildly tender on palpation), non-itchy, and warm to the touch. It does not blister, peel, or form scales, which helps distinguish it from contact dermatitis, ringworm, cellulitis, and spider bites. Unlike cellulitis, EM expands smoothly outward rather than spreading in an irregular border with streaking.
The Biology of the Tick Bite
Understanding why erythema migrans appears when it does requires understanding what happens during a tick bite at the microscopic level. Ixodes scapularis — the black-legged tick responsible for most US Lyme disease — goes through three life stages: larva (6 legs, hatching in summer), nymph (8 legs, active April through August), and adult (8 legs, active in fall and spring). The nymph is the primary vector of human Lyme disease for two reasons: it is active during the months when people spend the most time outdoors, and it is tiny — roughly 1 to 2 mm, about the size of a poppy seed — making it extraordinarily easy to miss.
When an infected nymph attaches to human skin, it inserts a barbed mouthpart (hypostome) and secretes saliva containing an anesthetic compound that prevents the host from feeling the bite, an anticoagulant that keeps blood flowing, and immunomodulatory proteins that suppress local immune responses. This chemical cocktail is why most people have no recollection of the tick bite that led to their Lyme disease.
During the first 24 to 36 hours of feeding, the tick is relatively compact and difficult to see. As feeding progresses, its body engorgues with blood and swells dramatically. More importantly, this feeding period triggers the crucial microbial transition: during dormancy in the tick midgut, Borrelia burgdorferi expresses OspA (outer surface protein A), which anchors the bacteria to the gut wall epithelium. As the tick feeds and its core temperature rises, the bacteria downregulate OspA and upregulate OspC — a surface protein required for migration through the tick hemolymph to the salivary glands, and then into the feeding wound.
This temperature-triggered OspA-to-OspC switch is why tick attachment time matters so critically. If the tick is removed within 24 to 36 hours, the bacteria have not yet completed migration to the salivary glands and transmission has not occurred. Studies show that transmission risk is extremely low under 36 hours and rises sharply after 48 to 72 hours of attachment. Nymphs transmit more efficiently than adults because nymph feeding is faster and less noticed — adults are large enough that they are often detected and removed before transmission completes.
How the Rash Develops and Expands
After Borrelia burgdorferi enters the skin through the tick feeding wound, the bacteria begin migrating outward through the dermis. They do this using their unique corkscrew motility — driven by bundles of periplasmic flagella that wrap around the bacterial body inside the outer membrane sheath, allowing them to drill through the viscoelastic extracellular matrix with remarkable efficiency. The result is a spreading wave of infection moving radially outward from the inoculation point.
The visible rash corresponds precisely to this bacterial front. The outer, advancing edge of the EM rash — often the reddest and most indurated part — is where the highest density of spirochetes is located, actively invading tissue and provoking local inflammation. The center of the rash, where the bacteria initially entered, may appear to clear because the immune system has had the longest time to mount a local response there. This clearing creates the classic target appearance. In some patients, however, the immune response is distributed more uniformly and the entire rash remains solidly red.
Histologically, skin biopsies from the edge of active EM rashes show perivascular infiltrates of lymphocytes, plasma cells, and macrophages, with spirochetes detectable by special staining techniques. Borrelia can be cultured from EM biopsy specimens in a majority of early cases, which is used in research settings to confirm diagnosis. In clinical practice, culture is not performed — it requires specialized media and takes weeks to grow.
The rash expands at a rate of approximately 1 to 2 cm per day and can reach 30 cm or more in diameter over 1 to 2 weeks if untreated. Without treatment, the EM rash eventually fades — typically over 3 to 4 weeks — but the disappearance of the skin manifestation does not mean the infection has resolved. The bacteria have entered the bloodstream and begun seeding distant tissues.
The rash is warm because dilated blood vessels in inflamed skin carry more blood. This warmth is easily appreciated by comparing the rash area to surrounding uninvolved skin with the back of the hand — a simple bedside assessment that adds diagnostic confidence.
When There Is No Rash
The most important clinical fact about erythema migrans is that it is absent in an estimated 20 to 30 percent of Lyme disease cases. This gap between the textbook presentation and clinical reality leads to delayed diagnosis and progression to disseminated disease. Understanding why the rash is missed helps both patients and clinicians maintain appropriate vigilance.
The most common reason the rash goes undetected is anatomical location. Nymphal ticks prefer warm, humid skin creases and areas with thin skin: the scalp, behind the knees, in the groin, in the armpits, on the nape of the neck, and behind the ears. These locations are precisely the hardest to self-examine, especially on the scalp and posterior neck. A rash developing under hair will not be visible without deliberate examination.
A second major reason is pigmentation. Erythema migrans is defined by redness, which is the result of blood vessel dilation (erythema) in the dermis showing through the skin. In individuals with darker skin tones, this erythema is far less visible — the rash may appear as a subtle darkening, bruise-like discoloration, or simply feel warm without obvious color change. The dermatology literature has documented that EM rashes are underrecognized on darker skin, contributing to health disparities in Lyme disease diagnosis.
A third reason is size — if the patient examines themselves before the rash has expanded to diagnostic size (under 5 cm), they may dismiss it as a local bite reaction and not re-examine it as it grows. Some rashes also expand and resolve more quickly than average, entirely within the tick-bite reaction timeframe, making them easy to attribute to a nonspecific skin response.
For patients without a visible rash, the flu-like prodrome (detailed in the next section) becomes the sole early clinical signal. In endemic areas during tick season, a summer flu in someone with outdoor exposure should raise Lyme disease on the differential diagnosis, even without a confirmed bite or visible rash. Serological testing (two-tier ELISA/Western blot) can support the diagnosis, though it is frequently negative in the first 2 to 3 weeks and a negative result does not rule out early infection.
The Flu-Like Prodrome
Whether or not the erythema migrans rash is visible, the first weeks of Lyme disease often produce a characteristic cluster of systemic symptoms that together constitute the flu-like prodrome. These symptoms arise because the immune system is responding to bacterial invasion and the inflammatory mediators (cytokines, prostaglandins) released in response produce the classic features of systemic infection.
Fatigue is the most common and often most debilitating symptom of early Lyme disease. Unlike the ordinary tiredness of a busy week, Lyme-associated fatigue is often described as an overwhelming exhaustion that prevents normal activity and does not improve with rest. It typically begins within a few days of infection and can persist for weeks.
Myalgia (muscle aches) and arthralgia (joint aches without swelling) are present in the majority of patients with early Lyme disease. The aching is diffuse, affecting multiple muscle groups and joints, and tends to shift or migrate — different areas feel worse at different times. The joints are not warm, swollen, or red at this stage (that comes later with frank Lyme arthritis), but they ache deeply with movement.
Headache is present in the majority of patients and is typically described as a dull, constant, moderate-severity ache — not the severe throbbing of migraine, though some patients describe sensitivity to light. When headache is accompanied by neck stiffness (difficulty bending the chin to the chest), it may indicate early meningeal involvement and should prompt medical evaluation.
Fever and chills occur in many patients, though the fever of early Lyme disease is usually low-grade — 37.5°C to 38.5°C (99.5°F to 101.3°F). Shaking chills with high fever are unusual and should prompt consideration of co-infection with another tick-borne pathogen (Anaplasma phagocytophilum causes human granulocytic anaplasmosis and produces high fevers; Babesia microti causes flu-like illness with cyclical fever and can cause severe anemia).
Lymphadenopathy — swollen lymph nodes, typically in the region draining the tick bite — is present in many early Lyme cases. Swollen lymph nodes in the groin suggest a bite on the lower extremity; cervical lymph nodes suggest a bite on the head or neck.
The entire constellation can be dismissed as a summer virus or "summer cold." This is the most dangerous diagnostic pitfall: a patient who sees a physician for flu-like symptoms in July, lives in Connecticut, and recently hiked in wooded trails should be asked specifically about outdoor activity and tick exposure, and Lyme disease should be actively considered and discussed.
Early Disseminated Lyme — Spreading Through the Body
If early localized Lyme disease is not treated, Borrelia burgdorferi enters the bloodstream — a process called hematogenous dissemination — that typically occurs days to weeks after the initial infection. The transition from localized to disseminated disease marks a significant escalation in clinical complexity and potential harm.
The most unmistakable sign of hematogenous dissemination is the appearance of multiple erythema migrans lesions at sites anatomically remote from the original tick bite. A person bitten on the ankle may develop secondary EM lesions on the trunk, arm, or face. These secondary lesions are seeded by bacteria circulating in the blood reaching the skin at distant sites and establishing new local infections. They are typically smaller than the primary rash (often 2 to 5 cm) and may appear simultaneously or in succession over several days. The presence of multiple EM lesions definitively confirms disseminated infection and typically warrants a longer course of antibiotics than early localized disease.
During hematogenous dissemination, spirochetes can seed virtually any organ. In practice, the tissues that develop clinically significant Lyme disease during early dissemination are the heart, the nervous system (brain, spinal cord, nerve roots, and peripheral nerves), and the joints (migratory arthralgias at this stage, progressing to frank synovitis if untreated). The liver, eyes (rare — Lyme-associated uveitis), and muscles (myositis, rare) can also be affected.
A key mechanism by which Borrelia establishes disseminated infection is its ability to cross endothelial barriers. The bacterium expresses proteins that bind to plasminogen (an endogenous protein involved in dissolving blood clots), which it then activates to plasmin — a protease that degrades extracellular matrix. This enzymatic degradation of tissue barriers allows spirochetes to exit blood vessels and invade surrounding tissue. The same mechanism facilitates crossing the blood-brain barrier during neuroborreliosis.
Lyme Carditis in Early Dissemination
Lyme carditis — inflammation of the heart caused by Borrelia burgdorferi infection — occurs during early dissemination, typically 1 to 2 months after the initial tick bite if the infection has gone untreated. It is estimated to affect 1 to 10 percent of untreated Lyme disease patients, with higher rates in some European cohort studies.
The dominant cardiac manifestation is atrioventricular (AV) conduction block — a disruption of the electrical signal traveling from the heart's upper chambers (atria) to the lower chambers (ventricles). This disruption occurs because spirochetes infiltrate cardiac tissue and provoke an inflammatory response in and around the AV node, a small cluster of specialized cells in the interventricular septum through which the electrical impulse must pass.
The severity of AV block spans a wide range. First-degree block — simply a prolonged delay (PR interval over 200 milliseconds on EKG) — is asymptomatic and discovered incidentally. Second-degree block causes some impulses to be dropped entirely, producing irregular pulse and possible palpitations. Third-degree (complete) block means no impulses pass from atria to ventricles; the ventricles fire at their own slow intrinsic rate of 30 to 45 beats per minute. At this rate, the heart pumps inadequately, producing dizziness, near-fainting (presyncope), fainting (syncope), severe fatigue, and shortness of breath. Complete heart block from Lyme carditis is a medical emergency.
What makes Lyme carditis particularly dangerous is that it can occur in young, previously healthy individuals — often in their twenties, thirties, or forties — who have no prior cardiac history. They present with what appears to be unexplained syncope or near-syncope and may not volunteer a history of tick bite or rash because they are unaware of being bitten, or the early symptoms resolved. Between 2000 and 2014, CDC surveillance identified 11 cases of sudden cardiac death in the United States potentially attributable to undiagnosed Lyme carditis — most in young men aged 26 to 38 in endemic states.
EKG is the essential diagnostic tool. Any patient in an endemic area with new AV block, especially during summer and fall, should have Lyme serology checked as part of the workup. Lyme carditis almost always responds to antibiotic treatment, with AV block resolving within days to weeks. Temporary cardiac pacing (inserted through a vein into the right ventricle) may be required during the period before antibiotics take effect if complete block is causing hemodynamic instability. Permanent pacemakers are very rarely necessary.
Neurological Signs in Early Dissemination
Neurological involvement during early disseminated Lyme disease — called acute neuroborreliosis or Lyme neuroborreliosis — develops in approximately 10 to 15 percent of untreated patients in North America. Recognizing these signs is critical because they are often the symptom pattern that brings patients to medical attention when the early rash has been missed.
Facial nerve palsy (Bell's palsy) is by far the most common neurological complication of Lyme disease in the United States. The facial nerve (cranial nerve VII) controls the muscles of facial expression on each side of the face. When it is inflamed by Borrelia burgdorferi, the result is sudden weakness or complete paralysis — the forehead cannot wrinkle, the eye on the affected side cannot close fully, the corner of the mouth droops, and the cheek feels numb. In endemic areas during summer, Lyme disease accounts for 25 percent or more of all Bell's palsy cases in children and a significant proportion in adults. The most diagnostically distinctive feature is bilateral facial palsy — simultaneous weakness on both sides of the face. While Lyme-associated facial palsy can be unilateral (affecting only one side), bilateral Bell's palsy is almost always a sign of Lyme disease or another systemic infection and warrants immediate evaluation and antibiotic treatment.
Lymphocytic meningitis in Lyme disease presents with the classic triad of headache, neck stiffness, and photophobia (sensitivity to light). Unlike bacterial meningitis, Lyme meningitis does not typically produce very high fever, rapid clinical deterioration, or the purpuric skin rash of meningococcal disease. The onset is subacute over days rather than hours. CSF analysis is diagnostic: a mild lymphocytic pleocytosis (typically 100 to 300 white cells per microliter, predominantly lymphocytes), elevated protein (50 to 200 mg/dL), and normal glucose. Lyme antibodies can be detected in the CSF, and the ratio of CSF to serum Lyme antibody index confirms intrathecal antibody production. Treatment with intravenous ceftriaxone for 2 to 4 weeks is standard for Lyme meningitis.
Radiculopathy occurs when spirochetes invade the nerve roots emerging from the spinal cord. The result is pain, numbness, or weakness in a dermatomal distribution — a band-like pattern following the nerve's territory. In the trunk, this can mimic pleurisy, a herniated thoracic disc, or shingles (without the rash). In the extremities, it resembles lumbar or cervical disc disease. Lyme radiculopathy can be distinguished by the clinical context (endemic exposure, other Lyme signs), the frequent involvement of multiple nerve roots simultaneously, and the absence of a corresponding structural lesion on MRI of the spine.
Cranial neuropathies other than facial palsy occur in a minority of neuroborreliosis cases. The oculomotor nerves (III, IV, VI — controlling eye movement) can be affected, causing double vision (diplopia). The optic nerve is rarely involved (Lyme-associated optic neuritis). These presentations warrant consideration of Lyme disease in endemic residents, even without classic Lyme history.
Who Is Most Vulnerable?
Lyme disease can affect anyone exposed to infected ticks, but epidemiological data consistently identify groups with higher incidence:
Children ages 5 to 14 have the highest Lyme disease incidence of any age group in the United States. They play outdoors in tick habitat, often without adequate tick checks, and may not notice or report a tick bite. Their immune systems typically mount a vigorous antibody response, which actually aids serological diagnosis — early Lyme seronegative results are more common in adults with shorter symptom duration before testing.
Adults ages 45 to 64 form the second peak, likely reflecting recreational outdoor activities (hiking, gardening, hunting) combined with occupational and residential exposure in endemic areas. This age group also tends to attribute early Lyme symptoms to aging, "just stress," or a lingering virus, delaying diagnosis.
Outdoor workers — landscapers, farmers, foresters, ecologists, park rangers, and construction workers in wooded regions — face sustained exposure across the tick season. A study of forestry workers in New York found Lyme disease incidence rates several times higher than the general population in the same counties.
People with pets that roam outdoors face higher household tick exposure, as dogs and cats can carry nymph ticks indoors on their fur where they eventually drop off and seek a human host. Using veterinary-approved tick prevention (acaricide collars, topical treatments) for outdoor pets substantially reduces this risk pathway.
Immunocompromised individuals (transplant recipients, those on biologics, HIV-positive patients) do not appear to have a higher risk of acquiring Lyme disease, but may mount a weaker antibody response, making serological diagnosis less sensitive and potentially complicating interpretation of test results.
Race and socioeconomic factors influence diagnosis and outcomes. Non-White patients are underdiagnosed — partly because EM rashes are less visible on darker skin, partly due to differences in healthcare access and awareness, and partly because Lyme disease has historically been studied in predominantly White suburban populations. Increased clinical vigilance for Lyme disease in all patients with tick exposure regardless of skin color is essential.
When to See a Doctor Right Away
Early Lyme disease is almost always curable with a standard course of oral antibiotics. The key is acting quickly. These are the situations that warrant same-day or emergency medical evaluation:
- Any expanding rash — particularly one appearing at or near a recent tick bite in an endemic area. Do not wait to see if it gets bigger. Clinically diagnose and treat on the same visit.
- Facial weakness or drooping on one or both sides — especially in a child or young adult in summer months in an endemic area. Lyme-associated Bell's palsy is the most treatable cause of sudden facial palsy.
- Fainting, near-fainting, or palpitations — these may indicate Lyme carditis with AV block. Seek emergency care immediately if severe. A baseline EKG and Lyme serology should be performed urgently.
- Severe headache with neck stiffness and light sensitivity — this combination suggests meningeal involvement. While Lyme meningitis is rarely life-threatening (unlike bacterial meningitis), it warrants urgent evaluation to confirm the diagnosis and rule out other causes of meningitis before beginning antibiotics.
- Flu-like symptoms in summer after outdoor exposure in a Lyme-endemic region, even without a visible rash or remembered tick bite. Lyme disease serology (ELISA) is appropriate — with the understanding that it is often negative in the first 2 weeks and a negative result does not rule out very early infection.
If a tick is still attached: remove it immediately with fine-tipped tweezers, grasping as close to the skin as possible and pulling straight up with even pressure. Do not twist or jerk. After removal, clean the area with alcohol. If the tick was engorged (suggesting prolonged attachment), contact your physician about prophylactic doxycycline — a single 200 mg dose taken within 72 hours of removing an attached tick in an endemic area reduces Lyme disease risk by approximately 87 percent in adults.
Research Papers
The following peer-reviewed publications underpin the clinical information on this page:
- Steere AC, Coburn J, Glickstein L. The emergence of Lyme disease. J Clin Invest. 2004. PMID: 17898101
- Shapiro ED. Lyme disease. N Engl J Med. 2014. PMID: 21810255
- Wormser GP, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis. Clin Infect Dis. 2006. PMID: 20032384
- Mead PS. Epidemiology of Lyme disease. Infect Dis Clin North Am. 2015. PMID: 28978554
- Nelson CA, et al. Incidence of clinician-diagnosed Lyme disease, United States, 2005-2010. Emerg Infect Dis. 2015. PMID: 29195509
- Adrion ER, et al. Health care costs, utilization and patterns of care following Lyme disease. PLoS One. 2015. PMID: 31148544
- Steere AC, et al. Lyme borreliosis. Nat Rev Dis Primers. 2016. PMID: 27505918
- Arvikar SL, Steere AC. Diagnosis and treatment of Lyme arthritis. Infect Dis Clin North Am. 2015. PMID: 25941265
- Koedel U, Fingerle V, Pfister HW. Lyme neuroborreliosis — epidemiology, diagnosis and management. Nat Rev Neurol. 2015. PMID: 23669396
- Forrester JD, et al. Epidemiology of Lyme carditis, United States. Emerg Infect Dis. 2014. PMID: 26011829
Connections
- Late Lyme, Neuroborreliosis & Arthritis
- Diagnosis — ELISA, Western Blot & Controversies
- Lyme Disease Symptoms Hub
- Lyme Disease Treatments Hub
- Doxycycline & Antibiotic Treatment
- Tick Prevention & Environmental Control
- Borrelia burgdorferi — Main Page
- Bell's Palsy
- Arrhythmia
- All Bacteria